Added to YB: 2025-10-22
Pitch date: 2025-09-03
WVE [bullish]
Wave Life Sciences, Inc.
-60.12%
current return
Author Info
No bio for this author
Company Info
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health.
Market Cap
$947.8M
Pitch Price
$8.00
Price Target
11.20 (+251%)
Dividend
N/A
EV/EBITDA
-2.45
P/E
-4.47
EV/Sales
7.66
Sector
Pharmaceuticals
Category
growth
Wave Life Sciences Ltd. - $WVE
WVE: Wave set to announce Phase 1b/2a results for WVE-006 (AATD) in coming days/weeks - success largely priced in but could position as best-in-class, generating $324M peak royalties to Wave via GSK deal. WVE-007 obesity asset targets novel INHBE pathway, synergistic with GLP-1s in preclinicals. Stock could gain +10-20% on WVE-006 success, +40% if WVE-007 proves viable in obesity market.
Read full article (16 min)